Selank.
About Selank
Selank is studied in the context of neuroscience and cognitive research. Selank is associated with allosteric modulation of the GABA system as well as inhibition of enkephalin-degrading enzymes.
Research Application
Studied in neuroscience research on anxiety and stress modulation. Approved as a prescription drug in Russia, but remains a research compound only in the US without FDA approval.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on neuroscience-related peptides are predominantly preclinical.
- Zozulya AA, et al. Zh Nevrol Psikhiatr. 2008. PMID 18454096
- Volkova A, et al. Front Pharmacol. 2016;7:31. PMID 26924987
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Question about Selank?
We reply personally – via email or Telegram.